Back to search results

Double Voiding to Prevent UTIs After Kidney Transplant

This study is looking at whether a technique called "double voiding" can help reduce urinary tract infections (UTIs) in people who have recently received a kidney transplant. UTIs are common after kidney transplants and can lead to other health problems. Double voiding means trying to empty your bladder twice each time you go to the bathroom. Researchers believe this might help by reducing the amount of urine left in the bladder. You could be eligible if you are an adult kidney transplant recipient who receives follow-up care at New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic, and do not have a Foley catheter (a tube to drain urine) when you leave the hospital. The study will measure the number of UTIs you experience in the first three months after your transplant. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 438 participants. It compares two groups: one instructed to double void and another that voids as usual.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for the number of UTIs during the first three months after transplantation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05711446

Double Voiding and Post-transplant UTI

Recruiting
NAAges 18+InterventionalPrevention
Weill Medical College of Cornell University
~438 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:Double VoidingRegular Voiding

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of UTI's
Measured over First 3 months of transplantation

Conditions

Urinary Tract Infections
Kidney Transplant; Complications

Explore related trials

Kidney TransplantationUrinary Tract Infection

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Muthukumar Thangamani, M.D. · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University

Who to contact

Muthukumar Thangamani, M.D.
[email protected]
212-746-9074
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic.

Exclusion

Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)

What this trial measures

  • Number of UTI'sFirst 3 months of transplantation

    UTI will be defined as a clean catch urine bacterial culture that is reported as anything other than "\<1000 CFU/ml (Colony Forming Unit / Milliliter)- Negative". Clean catch urine cultures are done at each follow-up visit as a standard of care, irrespective of patient symptoms. Hence the outcome will include both asymptomatic and symptomatic UTIs.